Ganoderma lucidum (Ganoderic acid A)

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Ganoderma lucidum (Ganoderic acid A).

Ganoderic acid A acts as a highly selective triterpenoid modulator of the NF-κB and AP-1 signaling pathways, exerting potent anti-inflammatory, hepatoprotective, and anti-tumorigenic effects through the inhibition of pro-inflammatory cytokine expression.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

11243918

Molecular Weight

313.4 g/mol

XLogP3 (Lipophilicity)

3.5

IUPAC Name

2-cyclopentyl-3-(4-fluorophenyl)-7-methyl-5,6,7,8-tetrahydro-4H-pyrazolo[3,4-d]azepine

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

Polysaccharides (β-glucans) for synergistic immunomodulation via Dectin-1 receptor activation
Vitamin C for enhanced antioxidant capacity and improved intestinal absorption of triterpenes

Biological Formulation Enhancers

Piperine for inhibition of P-glycoprotein-mediated efflux to increase systemic bioavailability
Quercetin for synergistic inhibition of inflammatory mediators and stabilization of triterpenoid structures

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Ganoderma lucidum (Ganoderic acid A) across standard consumer modalities.

💊 Standard Capsules

The hygroscopic nature of concentrated Reishi extracts requires moisture-resistant HPMC shells to prevent clumping and degradation of the triterpenoid profile.

🍬 Gummy & Pectin Formats

The inherent bitterness of Ganoderic acid A necessitates advanced flavor-masking agents and high-intensity sweeteners to overcome the organoleptic challenges in a pectin-based matrix.

🔬 Thin-Film Oral Strips

The high molecular weight and required therapeutic dosage of Ganoderic acid A significantly limit the payload capacity within the thin-film polymer matrix, potentially compromising mechanical integrity.

For Brand Founders

Formulate with Ganoderma lucidum (Ganoderic acid A)

Ready to launch a product featuring Ganoderma lucidum (Ganoderic acid A)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Ganoderma lucidum (Ganoderic acid A) Bioavailability

Need absolute proof that your Ganoderma lucidum (Ganoderic acid A) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Ganoderma lucidum (Ganoderic acid A) Degradation Testing

Is your Ganoderma lucidum (Ganoderic acid A) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation